[CAS NO. 4449-51-8] Cyclopamine

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [4449-51-8]

Catalog

HY-17024

Brand

MCE

CAS

4449-51-8

DESCRIPTION [4449-51-8]

Overview

MDL	MFCD09878269
Molecular Weight	411.62
Molecular Formula	C27H41NO2
SMILES	CC1=C2[C@@]([C@@]3([H])[C@]([C@@]4(C(C[C@@H](O)CC4)=CC3)C)([H])C2)([H])CC[C@@]15[C@@H]([C@@]6([H])[C@](C[C@H](C)CN6)([H])O5)C

For research use only. We do not sell to patients.

27 Publications Citing Use of MCE

Summary

Cyclopamine is a Hedgehog ( Hh ) pathway antagonist with an IC ₅₀ of 46 nM in the Hh cell assay. Cyclopamine is also a selective Smo inhibitor.

IC50 & Target

Human Endogenous Metabolite

In Vitro

Treatment with small molecule Hh inhibitors such as HhAntag and the natural product Cyclopamine, both binding to Smo, induces tumor remission in a genetic mouse model of medulloblastoma ^[1] . Cyclopamine is a Hedgehog (Hh) pathway antagonist. Cyclopamine suppresses cell growth. Cyclopamine (3 μM) suppression of Hh pathway activity and growth in digestive tract tumour cell lines correlates with expression of PTCHmRNA ^[2] . Cyclopamine is a steroidal alkaloid that inhibits Hh signalling through direct interaction with Smo ^[3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Cyclopamine causes durable regression of xenograft tumors. Tumors in Cyclopamine-treated animals, regress completely by 12 days ^[2] . Cyclopamine (1.2 mg) treatment blocks tumour formation of human pancreatic adenocarcinoma cells after transplantation into nude mice ^[3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Appearance

Solid

Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

Ethanol : 20 mg/mL ( 48.59 mM ; Need ultrasonic)

DMSO : 10 mg/mL ( 24.29 mM ; ultrasonic and warming and heat to 80°C)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.4294 mL	12.1471 mL	24.2943 mL
5 mM	0.4859 mL	2.4294 mL	4.8589 mL
10 mM	0.2429 mL	1.2147 mL	2.4294 mL

* Please refer to the solubility information to select the appropriate solvent.

In Vivo:

1.

Add each solvent one by one: 10% EtOH >> 90% corn oil

Solubility: ≥ 1.67 mg/mL (4.06 mM); Clear solution
2.

Add each solvent one by one: 10% DMSO >> 90% corn oil

Solubility: ≥ 1 mg/mL (2.43 mM); Clear solution
3.

Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

Solubility: ≥ 0.5 mg/mL (1.21 mM); Clear solution
4.

Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

Solubility: ≥ 0.5 mg/mL (1.21 mM); Clear solution

* All of the co-solvents are available by MCE.

References

Synonyms

Spiro[9H-benzo[a]fluorene-9,2′(3′H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3′a,4,4′,5′,6,6′,6a,6b,7,7′,7′a,8,11,11a,11b-octadecahydro-3′,6′,10,11b-tetramethyl-, (2′R,3S,3′R,3′aS,6′S,6aS,6bS,7′aR,11aS,11bR)-

Cyclopamine

Veratraman-3-ol, 17,23-epoxy-, (3β,23β)-

Jervine, 11-deoxo-

(2′R,3S,3′R,3′aS,6′S,6aS,6bS,7′aR,11aS,11bR)-1,2,3,3′a,4,4′,5′,6,6′,6a,6b,7,7′,7′a,8,11,11a,11b-Octadecahydro-3′,6′,10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2′(3′H)-furo[3,2-b]pyridin]-3-ol

11-Deoxyjervine

11-Deoxojervine

(-)-Cyclopamine